Axon Enterprise logo
Axon Enterprise AXON
$ 633.45 3.34%

Annual report 2024
added 05-07-2025

report update icon

Axon Enterprise Operating Cycle 2011-2026 | AXON

Annual Operating Cycle Axon Enterprise

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
116 518 123 112 88.8 197 202 181 184 134 174 138 143 140

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
518 88.8 175

Quarterly Operating Cycle Axon Enterprise

2025-Q1 2024-Q4 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
105 - - 147 151 139 - 59.4 113 105 - 96.6 102 114 - 120 155 100 - 70 75.7 70.6 - 78.6 85.4 98.3 - 102 122 120 - 126 148 124 - 74.5 90 104 - 107 120 96.1 - 99.3 129 110 - 130 139 132 - 44.1 50.7 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
155 44.1 106

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Aptorum Group Limited Aptorum Group Limited
APM
4.89 $ 1.06 -0.93 % $ 5.78 M chinaChina
Adagene Adagene
ADAG
53.8 $ 1.65 - $ 92.9 M chinaChina
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
8.75 $ 64.9 -0.15 % $ 8.68 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Biogen Biogen
BIIB
452 $ 187.4 0.75 % $ 27.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
244 $ 1.98 -1.0 % $ 5.02 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
135 $ 1.04 -2.34 % $ 142 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
410 $ 10.74 -2.1 % $ 707 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
86.5 $ 27.0 -1.28 % $ 1.74 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
136 $ 4.42 -1.34 % $ 116 M franceFrance
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
195 $ 27.75 0.02 % $ 1.34 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
408 $ 11.13 -2.02 % $ 720 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
360 $ 2.64 -0.75 % $ 16.6 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
AstraZeneca PLC AstraZeneca PLC
AZN
206 $ 94.65 0.68 % $ 96.9 B britainBritain
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA